TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer
2008 · British Journal of Cancer · 89 citations
https://doi.org/10.1038/sj.bjc.6604774
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
791
Citations
12
h-index
12
i10-index
Christopher J. Shepherd is an academic researcher from Cambridge University Hospitals NHS Foundation Trust. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Prostate Cancer Treatment and Research & Lung Cancer Treatments and Mutations. The author has an h-index of 12, co-authored 30 publications.
ORCID: 0000-0001-8540-815Xhttps://doi.org/10.1038/sj.bjc.6604774
https://doi.org/10.1097/rli.0000000000001245
Click to start Chat